Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

vTv Therapeutics Inc. VTVT

Full chart Compare
Set alert

Price alert · VTVT

All alert types
21.03 USD -0.71 (-3.27%)

At closeNov 6, 2026, 4:00 PM EST

21.03 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

20.56 Day range 22.20
21.03 52-week range 42.72
YTD
-47.41%
1 year
-17.43%

Financial health

Altman Z-Score

1.71 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -12.5×
FY 2016: -2.8×FY 2017: -3.6×FY 2018: -4.2×FY 2019: -2.3×FY 2020: -10.3×FY 2021: -4.8×FY 2022: -2.7×FY 2023: -1.2×FY 2024: -4.3×FY 2025: -12.5×
FY 2016 5y median -4.3× FY 2025
P/S 0.0×
FY 2016: 72.7×FY 2017: 200×FY 2018: 2.7×FY 2019: 18.6×FY 2020: 13.7×FY 2021: 15.6×FY 2022: 25.2×FY 2023: 0.0×FY 2024: 78.4×FY 2025: 0.0×
FY 2016 5y median 15.6× FY 2025
P/B 5.2×
FY 2016: -0.5×FY 2017: -0.4×FY 2018: -0.4×FY 2019: -1.1×FY 2020: -1.1×FY 2021: -6.4×FY 2022: -4.7×FY 2023: -1.0×FY 2024: 6.5×FY 2025: 5.2×
FY 2016 5y median -1.0× FY 2025
P/FCF -13.3×
FY 2016: -1.0×FY 2017: -1.3×FY 2018: -1.2×FY 2019: -2.2×FY 2020: -4.9×FY 2021: -3.2×FY 2022: -3.3×FY 2023: -1.3×FY 2024: -3.1×FY 2025: -13.3×
FY 2016 5y median -3.2× FY 2025
EV/EBITDA -8.0×
FY 2016: -0.1×FY 2017: -1.3×FY 2018: -2.3×FY 2019: -2.8×FY 2020: -6.9×FY 2021: -2.8×FY 2022: -1.6×FY 2023: -0.6×FY 2024: -1.9×FY 2025: -8.0×
FY 2016 5y median -1.9× FY 2025
EV/Sales 0.0×
FY 2016: 8.9×FY 2017: 227×FY 2018: 3.8×FY 2019: 20.6×FY 2020: 12.9×FY 2021: 12.4×FY 2022: 19.6×FY 2023: 0.0×FY 2024: 42.4×FY 2025: 0.0×
FY 2016 5y median 12.4× FY 2025
FCF Yield -7.5%
FY 2016: -104.8%FY 2017: -76.6%FY 2018: -81.4%FY 2019: -44.8%FY 2020: -20.5%FY 2021: -31.0%FY 2022: -30.0%FY 2023: -79.6%FY 2024: -31.8%FY 2025: -7.5%
FY 2016 5y median -31.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -7115.8%FY 2017: -13522.0%FY 2018: -85.3%FY 2019: -447.0%FY 2020: -71.7%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2016: -8678.2%FY 2017: -17416.5%FY 2018: -159.4%FY 2019: -755.9%FY 2020: -184.8%FY 2021: -540.9%FY 2022: -1116.9%FY 2023: 0.0%FY 2024: -2377.6%FY 2025: 0.0%
FY 2016 5y median -540.9% FY 2025
Net Margin 0.0%
FY 2016: -2579.2%FY 2017: -5547.8%FY 2018: -63.6%FY 2019: -793.7%FY 2020: -132.5%FY 2021: -324.3%FY 2022: -949.7%FY 2023: 0.0%FY 2024: -1815.3%FY 2025: 0.0%
FY 2016 5y median -324.3% FY 2025
ROE -41.9%
FY 2016: 18.0%FY 2017: 10.7%FY 2018: 9.5%FY 2019: 44.8%FY 2020: 10.6%FY 2021: 133.3%FY 2022: 178.4%FY 2023: 82.1%FY 2024: -151.3%FY 2025: -41.9%
FY 2016 5y median 82.1% FY 2025
ROIC -39.4%
FY 2016: -127.8%FY 2017: -963.7%FY 2018: 2215.0%FY 2019: -964.1%FY 2020: -137.2%FY 2021: -124.4%FY 2022: -87.0%FY 2023: -3359.9%FY 2024: -72.7%FY 2025: -39.4%
FY 2016 5y median -87.0% FY 2025
ROA -30.0%
FY 2016: -30.0%FY 2017: -57.8%FY 2018: -92.4%FY 2019: -236.8%FY 2020: -57.5%FY 2021: -51.0%FY 2022: -57.7%FY 2023: -183.8%FY 2024: -48.2%FY 2025: -30.0%
FY 2016 5y median -51.0% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 22.2%FY 2017: -54.1%FY 2018: 4172.9%FY 2019: -77.8%FY 2020: 132.1%FY 2021: -37.6%FY 2022: -49.6%FY 2023: -100.0%FY 2024: 0.0%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -35.7%
FY 2016: -44.3%FY 2017: 7.9%FY 2018: 60.9%FY 2019: -5.4%FY 2020: 43.3%FY 2021: -82.8%FY 2022: -4.1%FY 2023: -13.1%FY 2024: 5.2%FY 2025: -35.7%
FY 2016 FY 2025
EPS (diluted) 0.0%
FY 2016: 48.4%FY 2017: 2.8%FY 2018: 61.8%FY 2019: -14.0%FY 2020: 75.1%FY 2021: -15.0%FY 2022: -20.4%FY 2023: 2.7%FY 2024: 67.0%FY 2025: 0.0%
FY 2016 FY 2025
Free Cash Flow 0.2%
FY 2016: -30.4%FY 2017: 7.6%FY 2018: 39.8%FY 2019: 14.0%FY 2020: 22.0%FY 2021: -7.3%FY 2022: 20.9%FY 2023: -25.0%FY 2024: -32.6%FY 2025: 0.2%
FY 2016 FY 2025

Financial Health

Current Ratio 13.5×
FY 2016: 4.6×FY 2017: 0.8×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 1.1×FY 2021: 1.8×FY 2022: 3.5×FY 2023: 1.0×FY 2024: 7.3×FY 2025: 13.5×
FY 2016 5y median 3.5× FY 2025
Quick Ratio 13.5×
FY 2016: 4.6×FY 2017: 0.8×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 1.1×FY 2021: 1.8×FY 2022: 3.5×FY 2023: 1.0×FY 2024: 7.3×FY 2025: 13.5×
FY 2016 5y median 3.5× FY 2025
Debt / Equity 0.0×
FY 2016: -0.1×FY 2017: -0.1×FY 2018: -0.2×FY 2019: -0.1×FY 2020: -0.0×FY 2021: -0.1×FY 2022: -0.1×FY 2023: -0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median -0.0× FY 2025
Net Debt / EBITDA 2.9×
FY 2016: 0.7×FY 2017: -0.2×FY 2018: -0.7×FY 2019: -0.3×FY 2020: 0.4×FY 2021: 0.7×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 1.6×FY 2025: 2.9×
FY 2016 5y median 0.7× FY 2025
Interest Coverage -5468×
FY 2016: -138×FY 2017: -16.4×FY 2018: -6.0×FY 2019: -11.4×FY 2020: -17.1×FY 2021: -1805×FY 2022: -1503×FY 2023: -1962×FY 2024: 0.0×FY 2025: -5468×
FY 2016 5y median -1805× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31